A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program

Carrie A. Thompson; Jane Tiedt; Mirjeta Beqiri; Deborah W. Smith

doi:10.1016/j.nurpra.2021.12.013

A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program

Carrie A. Thompson, Jane Tiedt, Mirjeta Beqiri, Deborah W. Smith

Hematology

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. Aim: To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program. Methods: The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients. Conclusions: Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.

Original language	English (US)
Pages (from-to)	276-284
Number of pages	9
Journal	Journal for Nurse Practitioners
Volume	18
Issue number	3
DOIs	https://doi.org/10.1016/j.nurpra.2021.12.013
State	Published - Mar 2022

Keywords

cancer genetic screening
gastroenterology
nurse practitioner
outcomes
surveillance

ASJC Scopus subject areas

Advanced and Specialized Nursing

Access to Document

10.1016/j.nurpra.2021.12.013

Cite this

@article{d15bf023caff43169a547caeeb590521,

title = "A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program",

abstract = "Background: Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. Aim: To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program. Methods: The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients. Conclusions: Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.",

keywords = "cancer genetic screening, gastroenterology, nurse practitioner, outcomes, surveillance",

author = "Thompson, {Carrie A.} and Jane Tiedt and Mirjeta Beqiri and Smith, {Deborah W.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2022",

month = mar,

doi = "10.1016/j.nurpra.2021.12.013",

language = "English (US)",

volume = "18",

pages = "276--284",

journal = "Journal for Nurse Practitioners",

issn = "1555-4155",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program

AU - Thompson, Carrie A.

AU - Tiedt, Jane

AU - Beqiri, Mirjeta

AU - Smith, Deborah W.

PY - 2022/3

Y1 - 2022/3

N2 - Background: Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. Aim: To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program. Methods: The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients. Conclusions: Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.

AB - Background: Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. Aim: To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program. Methods: The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients. Conclusions: Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.

KW - cancer genetic screening

KW - gastroenterology

KW - nurse practitioner

KW - outcomes

KW - surveillance

UR - http://www.scopus.com/inward/record.url?scp=85123070085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123070085&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2021.12.013

DO - 10.1016/j.nurpra.2021.12.013

M3 - Article

AN - SCOPUS:85123070085

SN - 1555-4155

VL - 18

SP - 276

EP - 284

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

IS - 3

ER -

A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this